Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Maravai Lifesciences Holdings Inc Cl A (MRVI)

Maravai Lifesciences Holdings Inc Cl A (MRVI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Maravai Lifesciences Holdings Inc Cl A 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 USA

P: 858-546-0004

Description:

Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 3,677,533
Enterprise Value, $K 3,656,853
Shares Outstanding, K 255,207
Annual Sales, $ 799,240 K
Annual Net Income, $ 182,040 K
Last Quarter Sales, $ 191,260 K
Last Quarter Net Income, $ 44,470 K
60-Month Beta -0.25
% of Insider Shareholders 0.11%
% of Institutional Shareholders 48.67%
Float, K 254,926
% Float 99.89%
Short Volume Ratio 0.44

Growth:

1-Year Return -46.30%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.37 on 11/02/22
Next Earnings Date 02/22/23
Earnings Per Share ttm 1.90
EPS Growth vs. Prev Qtr -31.48%
EPS Growth vs. Prev Year -15.91%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MRVI Ratios

Ratio
Price/Earnings ttm 7.63
Price/Earnings forward 42.12
Price/Earnings to Growth N/A
Return-on-Equity % 69.19%
Return-on-Assets % 23.24%
Profit Margin % 22.78
Net Margin % N/A
Debt/Equity 0.62
Price/Sales 4.07
Price/Cash Flow 8.42
Price/Book 4.40
Book Value/Share 3.30
Interest Coverage 18.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar